Belgium· BE-AMP-SAM477733-00
Jinarc 30 mg - 90 mg
A tolvaptan product containing tolvaptan, registered in Belgium by Otsuka Pharmaceutical Netherlands. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Tolvaptan is registered in 13 of 19 countries.
Countries holding a registration under ATC C03XA01 (tolvaptan), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Tolvaptan · ATC C03XA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of tolvaptan costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $1.82 in Czechia to $127.86 in Italy — a ×70 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tolvaptan · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- IT Italy$127.86
- CH Switzerland$72.80
- FR France$14.28
- CZ Czechia$1.82
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Tolvaptan
- Manufacturer
- Otsuka Pharmaceutical Netherlands
- Country
- Belgium (BE)
- ATC code
- C03XA01
- ATC class
- Tolvaptan
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb3451994
- be_apb7716012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
183 interactions on record for tolvaptan.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tolvaptan · interactions on record
183 records
- 16 severe
- 161 moderate
- 6 minor
Most severe, free to view
- KetoconazoleH02CA03severe
- ClarithromycinJ01FA09severe
- KetoconazoleJ02AB02severe
- Darunavir and cobicistatJ05AR14severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tolvaptan in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandGurdatolSandoz A/S
- United KingdomJinarc 15mg tabletsOtsuka Pharmaceuticals (U.K.) Ltd
- CzechiaJINARCOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- United StatesJYNARQUEOtsuka America Pharmaceutical, Inc.
- SpainJINARC 15 mg + 45 mg COMPRIMIDOSOtsuka Pharmaceutical Netherlands B.V.
- SwedenJinarc 15 mg TablettOtsuka Pharmaceutical Netherlands B.V.
- NorwayJinarcOtsuka Pharmaceutical Netherlands B.V.
- NetherlandsJinarc 15 mg, tabletOtsuka Pharmaceutical Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Tolvaptan, Tolvaptan +pharma
- Czechia · Tolvaptan Stada
- Germany · Tolvaptan, Tolvaptan 1 A Pharma
- Estonia · Tolvaptan Stada
- Spain · Tolvaptán Sandoz, Tolvaptan Stadafarma
- France · Tolvaptan Biogaran, Tolvaptan Eg
- United Kingdom (Northern Ireland) · Tolvaptan, Tolvaptan Genus Pharmaceuticals
- Greece · Gurdatol, Pokydy
- Croatia · Gurdatol
- Ireland · Tolvaptan Ascend
- Iceland · Gurdatol, Jinarc
- Italy · Tolvaptan Teva, Tolvaptan Teva Italia
- Liechtenstein · Jinarc, Samsca
- Lithuania · Tolvaptan Stada
- Latvia · Tolvaptan Stada
- Netherlands · Tolvaptan Sandoz, Tolvaptan Teva
- Norway · Jinarc, Samsca
- Poland · Tolvaptan Sandoz
- Portugal · Tolvaptano Stada, Tolvaptano Stada 15 Mg + 45 Mg Comprimidos
- Sweden · Tolvaptan Hexal, Tolvaptan Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d78eba56-9786-4eba-b751-f7ab1a9ed306 GET /v1/drugs/d78eba56-9786-4eba-b751-f7ab1a9ed306?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Jinarc 30 mg - 90 mg",
"name_fr": "Jinarc 30 mg - 90 mg",
"name_nl": "Jinarc 30 mg - 90 mg",
"amp_code": "SAM477733-00",
"strengths": [
"30.0000",
"30.0000",
"70.0000",
"70.0000",
"90.0000",
"90.0000",
"24.0000",
"24.0000"
],
"pack_count": 6,
"substances": [
"Tolvaptan",
"Lactose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Tolvaptan",
"authorisation_numbers": [
"EU/1/15/1000/012",
"EU/1/15/1000/011",
"EU/1/15/1000/013",
"EU/1/15/1000/020",
"EU/1/15/1000/021",
"EU/1/15/1000/022"
]
}See everything about tolvaptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.